Cogent Biosciences, Inc. (NASDAQ: COGT) is a Healthcare company (Biotechnology) with a market capitalization of $4.8B. The Maz Rating grades it against the other companies in its sector.
Cogent Biosciences, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $27.85, Cogent Biosciences, Inc. trades at 9.3x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -71.1%, return on invested capital of -55.6% and a free cash flow yield of -6.8%. On the balance sheet: a debt-to-equity ratio of 0.47 and a current ratio of 10.99. Over the past 52 weeks the share price ranged from $26.36 to $43.73, with a beta of 0.34.
Cogent Biosciences, Inc. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 10 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.